What should the NPH insulin dose be for a patient with type 2 diabetes on Lantus (Insulin Glargine) 27 units, who received 6 units of fast-acting insulin and has a blood glucose level of 344?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 14, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

NPH Insulin Dosing for Tube-Fed Patient with Steroid-Induced Hyperglycemia

Direct Recommendation

This patient should NOT receive NPH insulin at all—she should continue her Lantus 27 units and have her correctional insulin regimen optimized instead. 1, 2

Clinical Reasoning

Why NPH is Not Indicated Here

  • NPH insulin is specifically recommended for steroid-induced hyperglycemia to match the pharmacokinetic profile of glucocorticoids, which peak 4-8 hours after morning administration 1, 3
  • There is no mention of steroid therapy in this patient, making NPH an inappropriate choice for basal insulin coverage 1
  • The patient already has adequate basal insulin coverage with Lantus 27 units (approximately 0.33 units/kg), which is within the appropriate range for type 2 diabetes 4

The Real Problem: Inadequate Correctional Insulin

  • The blood glucose of 344 mg/dL after only 6 units of correctional insulin indicates the correction scale is insufficient, not that basal insulin needs changing 1, 3
  • For a patient with this degree of hyperglycemia and insulin resistance (BMI 29), the correction factor should be approximately 1 unit per 20-25 mg/dL above target using the "1800 rule" 3
  • A blood glucose of 344 mg/dL should have received approximately 10-12 units of correctional insulin (assuming target of 120-140 mg/dL), not 6 units 3

Appropriate Management Strategy

Optimize the correctional insulin scale:

  • Blood glucose 150-200 mg/dL: 2-3 units 3
  • Blood glucose 201-250 mg/dL: 4-5 units 3
  • Blood glucose 251-300 mg/dL: 6-8 units 3
  • Blood glucose 301-350 mg/dL: 10-12 units 3
  • Blood glucose >350 mg/dL: 12-14 units and notify provider 3

Consider scheduled prandial coverage for tube feeding:

  • With 188 grams of carbohydrates over 24 hours (approximately 63 grams per 8-hour period), consider adding scheduled rapid-acting insulin 4
  • Start with 4-6 units of rapid-acting insulin every 8 hours to cover the continuous carbohydrate load, using a ratio of approximately 1 unit per 10-12 grams of carbohydrate 3
  • This approach is superior to relying solely on correctional insulin for continuous tube feeding 4

If Basal Insulin Adjustment is Needed

  • If fasting glucose remains elevated despite adequate correctional coverage, increase Lantus by 2 units every 3 days until fasting glucose reaches 100-140 mg/dL 1, 2
  • The current Lantus dose of 27 units may need titration upward to 0.4-0.5 units/kg (32-40 units) given the degree of hyperglycemia 1

Common Pitfalls to Avoid

  • Do not switch from Lantus to NPH without a specific indication (such as steroid therapy)—Lantus provides more consistent 24-hour basal coverage with less nocturnal hypoglycemia than NPH 5, 6
  • Do not rely solely on correctional insulin for tube-fed patients—scheduled prandial insulin prevents the "chasing" pattern that leads to persistent hyperglycemia 4
  • Monitor blood glucose every 4-6 hours while adjusting the regimen to identify patterns and prevent both hyperglycemia and hypoglycemia 1, 3

References

Guideline

Management of Steroid-Induced Hyperglycemia with NPH Insulin

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Converting from 70/30 to NPH Insulin in Hospitalized Patients with Hyperglycemia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hyperglycemia in Post-Kidney Transplant Patients on High-Dose Steroids

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Insulin glargine (Lantus).

International journal of clinical practice, 2002

Related Questions

What is the equivalent NPH (Neutral Protamine Hagedorn) insulin dose for a patient taking 20 units of Lantus (insulin glargine)?
What is the equivalent dose of NPH (Neutral Protamine Hagedorn) insulin for a patient taking 15 units of Lantus (insulin glargine)?
What is the appropriate initial NPH dose for a post-liver and kidney transplant patient with impaired renal function on Lantus (insulin glargine) and an insulin drip?
How to adjust Lantus (insulin glargine) for a type 2 diabetes patient who will be NPO (nothing by mouth) at midnight?
How should Lantus (insulin glargine) and NPH (Neutral Protamine Hagedorn) insulin doses and carb ratio be adjusted for a patient on prednisone with improved fasting blood glucose?
What dose of allopurinol should I increase to from 100 mg three times daily for better control of my hyperuricemia?
What is the role of Isuprel (isoproterenol) in managing ventricular tachycardia (VT) storm?
Will consuming Pedialyte (electrolyte-rich oral rehydration solution) 12 hours prior to a 24-hour urine collection test affect the accuracy of the results for diagnosing Diabetes Insipidus?
Can a patient on warfarin (anticoagulant) take colchicine (anti-gout medication)?
What should the NPH (Neutral Protamine Hagedorn) insulin dose be for a 60-year-old female with type 2 diabetes, body mass index (BMI) of 29, and severe hyperglycemia, currently receiving tube feeding (TF) with 94 grams of carbohydrates (CHO) over 12 hours and 6 units of Novolog (insulin aspart)?
Will consuming Pedialyte (electrolyte-rich oral rehydration solution) 12 hours prior to a 24-hour urine collection test affect the accuracy of the results for diagnosing Diabetes Insipidus?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.